Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
N4-Acetylcytidine in RNA Epigenetics: Protocols and Innovati
2026-07-17
N4-Acetylcytidine is redefining RNA epigenetics research by enabling high-precision analyses of post-transcriptional modifications. APExBIO’s high-purity formulation supports reproducible workflows and advanced troubleshooting for RNA modification studies.
-
KPT330 Enhances Precision in CRISPR-Cas9 Editing via mRNA Ex
2026-07-17
The referenced study reveals that KPT330, a selective inhibitor of nuclear export (SINE), increases the specificity of CRISPR-Cas9 genome and base editing by modulating the nuclear export of Cas9 mRNA. This introduces an indirect, small-molecule approach to improve editing precision, with practical implications for researchers seeking to minimize off-target effects in mammalian systems.
-
Structure-Based Discovery of NSP15 Inhibitors in SARS-CoV-2
2026-07-16
This study leveraged structure-guided virtual screening of natural products to identify thymopentin and oleuropein as potent NSP15 inhibitors in SARS-CoV-2. These findings provide a framework for antiviral drug development targeting viral immune evasion mechanisms.
-
U-73122: Precision Phospholipase C Inhibitor for Advanced As
2026-07-16
U-73122 delivers targeted, reproducible inhibition of the PLC signaling pathway, empowering researchers to dissect calcium flux and chemotaxis with unmatched selectivity. Recent studies and scenario-driven resources showcase its superior performance in cancer, inflammation, and signal transduction workflows—making it a cornerstone for modern assay development.
-
Murine RNase Inhibitor: Oxidation-Resistant RNA Protection
2026-07-15
Murine RNase Inhibitor provides robust, oxidation-resistant protection against RNA degradation, making it essential for RNA-based molecular biology workflows. As a recombinant mouse RNase A inhibitor, it outperforms traditional inhibitors, especially in real-time RT-PCR and cDNA synthesis applications.
-
Prednisone as a Precision Immunomodulator: Mechanisms and Re
2026-07-15
Explore the multifaceted mechanisms of Prednisone, a synthetic corticosteroid, in immunology and neurodegeneration research. This article offers an advanced, evidence-based perspective on apoptosis induction, cell cycle arrest, and assay design—expanding beyond standard protocols with unique cross-domain insights.
-
Bestatin (Ubenimex): Mechanistic Insights and Assay Innovati
2026-07-14
Explore Bestatin (Ubenimex) as a precision aminopeptidase inhibitor. This article uncovers advanced mechanistic understanding, practical assay strategies, and cross-disciplinary applications that set it apart in multidrug resistance and apoptosis research.
-
CFTRinh-172 in Epithelial Biology: Selective Inhibition and
2026-07-14
Explore how CFTRinh-172, a potent CFTR inhibitor, enables precision modeling of chloride channel function in epithelial research. This article uncovers new assay strategies and integrates recent advances in CFTR trafficking for cystic fibrosis and secretory diarrhea studies.
-
Optimizing Apoptosis Detection with Annexin V-FITC/PI Apopto
2026-07-13
This article guides biomedical researchers in overcoming common pitfalls of apoptosis assays using the Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003). Drawing on real-world laboratory scenarios and recent literature, it details how this workflow-ready solution from APExBIO ensures robust, reproducible discrimination of cell death stages. Explore practical protocol advice, data interpretation strategies, and vendor selection insights to enhance experimental reliability.
-
Ferrocenyl Novobiocin Derivatives: Antimalarial and Anticanc
2026-07-13
This study presents the synthesis and biological evaluation of ferrocenyl and organic novobiocin derivatives, highlighting how the introduction of a ferrocene moiety enhances activity against Plasmodium falciparum and human breast cancer cells. These findings provide a promising direction for overcoming resistance in antimalarial and anticancer drug development.
-
Rapid Differentiation of HepaRG Cells for HBV and HDV Infect
2026-07-12
Lucifora et al. introduce a fast differentiation protocol for HepaRG cells that significantly reduces culture time while preserving susceptibility to Hepatitis D virus (HDV) and partially to Hepatitis B virus (HBV) infection. This streamlined approach facilitates mechanistic studies of viral entry and replication in hepatocyte-like cells, advancing the field of hepatotropic virus research.
-
SIS3 (Smad3 inhibitor): Precision in TGF-β Signaling Researc
2026-07-10
SIS3, a selective Smad3 inhibitor from APExBIO, is redefining TGF-β pathway research by enabling targeted suppression of fibrosis and cartilage degradation pathways. This article bridges advanced mechanistic insights with practical workflows, offering troubleshooting and optimization strategies for reproducible results in fibrosis and osteoarthritis models.
-
Ibotenic Acid in Translational Neurotoxicity: From Mechanism
2026-07-09
Explore how Ibotenic acid, a potent NMDA receptor agonist, bridges mechanistic neurotoxicity with translational animal model design. Uncover new insights into dose-response, assay selection, and practical safety considerations for neuroscience research.
-
RUBCN Identified as Prognostic Biomarker in Breast Cancer
2026-07-09
A recent study establishes RUBCN as a prognostic marker and therapeutic target in breast cancer, integrating multi-omics analysis with functional cell assays. This work highlights both the mechanistic significance of RUBCN in tumor progression and the utility of advanced cell proliferation assays for translational oncology research.
-
Trelagliptin Succinate: Applied Workflows in Diabetes & OA M
2026-07-08
Trelagliptin succinate (SYR-472 succinate) is redefining type 2 diabetes and osteoarthritis research by offering selective, long-acting DPP-4 inhibition with robust anti-inflammatory and metabolic benefits. This guide delivers a protocol-driven approach, troubleshooting tips, and scenario-based optimization rooted in recent breakthroughs and real-world lab challenges.